Adlai Nortye Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Adlai Nortye Ltd. is a global clinical-stage biopharmaceutical company primarily engaged in developing innovative immuno-oncology medicines. The company's mission is to improve patient lives by discovering and developing differentiated innovative treatments for cancer. It has a strategic focus on oncology, with research and development and global clinical operation centers located in the United States and China. The company is headquartered in North Brunswick, New Jersey, and its shares are listed on the Nasdaq.
Key slides for Adlai Nortye Ltd
Corporate Presentation
Adlai Nortye Ltd
Corporate Presentation
Adlai Nortye Ltd
Latest articles
The Birkin Bag: The Story Behind the World's Most Desired Handbag
How the Birkin bag became the world's most sought-after handbag where even the wealthy must earn the right to own one.
12 Jul 2024
The 10 Largest Semiconductor Companies in the World
Discover the top 10 semiconductor companies by market cap, exploring their innovations and business models shaping the tech landscape.
10 Jul 2024
The Rise of Nubank: Changing Latin American Finance
Discover how Nubank revolutionized Latin American banking with innovation, backed by top investors like Berkshire Hathaway.
9 Jul 2024
Ticker symbol
ANL
Country
🇺🇸 United States